PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION AT TWO YEARS AFTER TREATMENT WITH INVESTIGATIONAL MICROBIOTA-BASED DRUG RBX2660: EFFICACY, DURABILITY, MICROBIOME CHANGES, AND PARTICIPANT DEMOGRAPHICS OF A PHASE 2 OPEN-LABEL CLINICAL TRIAL

Christina Reimer ¹ Robert Orenstein ² Lindy Bancke ³ Carlos A Gonzalez ⁴ Ken Blount ⁴
¹ Ferring Pharmaceuticals A/S, Copenhagen, Denmark
² Mayo Clinic in Arizona, Phoenix, United States
³ Rebiotix Inc., Roseville, United States
⁴ BioRankings, LLC, St. Louis, United States

Session
Other lower GI disorders (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing